- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Non-Muscle Invasive Bladder Neoplasms in Austria
Total 1105 results
-
Daiichi Sankyo, Inc.AstraZeneca; NSABP Foundation Inc; German Breast Group; Spanish Breast Cancer Research...Active, not recruitingHER2-Positive Primary Breast Cancer | Residual Invasive Breast CancerUnited States, Spain, France, Germany, Korea, Republic of, United Kingdom, Denmark, Israel, Belgium, Taiwan, Chile, Italy, Japan, Peru, Portugal, China, Turkey, Canada, Ireland, Australia, Greece, Czechia, Singapore, Poland, Romania, Arge... and more
-
AbbVieCompletedNon-squamous Non-small Cell Lung CancerUnited States, Argentina, Australia, Canada, Czechia, Denmark, Finland, Germany, Hungary, Israel, Japan, Korea, Republic of, Netherlands, New Zealand, Russian Federation, South Africa, Spain, Taiwan, Turkey, United Kingdom
-
Mirati Therapeutics Inc.Active, not recruitingAdvanced Non Small Cell Lung Cancer | Metastatic Non Small Cell Lung CancerUnited States, Spain, Belgium, France, Germany, Hungary, Italy, United Kingdom, Korea, Republic of, Poland, Australia, Switzerland, Singapore, Netherlands, Romania, Czechia, Greece, Ireland, Austria, Russian Federation, Portugal, Hong... and more
-
TakedaActive, not recruitingRelapsed or Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)United States
-
TakedaActive, not recruitingAdvanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)United States, Spain, France, Korea, Republic of, Hong Kong, Australia, Taiwan, United Kingdom, Canada, Turkey, Italy, China, Germany, Japan, Austria, Belgium, Greece, Israel, Netherlands, Portugal, Russian Federation, Singapore, Sw... and more
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerAustralia, France, Germany, Spain, China, Hong Kong, Canada, Sweden, Colombia, Taiwan, United Kingdom, Russian Federation, Finland, Austria, Estonia, Hungary, Netherlands, Latvia, Italy, Mexico, Slovenia, Turkey, Bosnia and Herzegovina and more
-
Peter MacCallum Cancer Centre, AustraliaAbbVieNot yet recruitingRelapsed/Refractory Large B-cell LymphomaAustralia
-
PfizerRecruitingLocally Advanced or Metastatic ER+ HER2- Breast Cancer | Locally Advanced or Metastatic Castration-resistant Prostate Cancer | Locally Advanced or Metastatic Non-small Cell Lung CancerUnited States, China, Australia, Korea, Republic of, Japan
-
AmgenCompletedNon Small Cell Lung CancerUnited States, Canada, Australia, Spain, Belgium, Greece
-
Bristol-Myers SquibbActive, not recruitingNon-Small Cell Lung Cancer (NSCLC)Russian Federation, United States, Argentina, Australia, Belgium, Brazil, Canada, Chile, China, France, Germany, Greece, Ireland, Italy, Japan, Korea, Republic of, Mexico, Netherlands, Poland, Puerto Rico, Romania, Spain, Sweden, Swit... and more
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedLung CancerUnited States, Australia, Peru, Puerto Rico
-
Merck Sharp & Dohme LLCModernaTX, Inc.RecruitingNon-small Cell Lung CancerPoland, United States, New Zealand, Australia, Costa Rica, Taiwan, Argentina, France, Chile, Hungary, Spain, Greece, Canada, Lithuania, Norway, Italy, Czechia, Estonia, Portugal
-
PfizerCompletedSystemic Anaplastic Large-Cell Lymphoma | Non-Small Cell Lung Cancer ALK-positive | Non-Small Cell Lung Cancer c-Met Dependent | Non-Small Cell Lung Cancer ROS Marker Positive | Advanced Malignancies Except LeukemiaUnited States, Korea, Republic of, Australia, Japan
-
Novartis PharmaceuticalsActive, not recruitingNon-small Cell Lung CancerUnited States, Canada, Italy, Spain, Malaysia, Taiwan, Turkey, Australia, Germany, Netherlands, Singapore, Argentina, Austria, Czechia, Switzerland, United Kingdom, Korea, Republic of, Thailand, France, Japan, Lebanon, Greece, Hong... and more
-
Astellas Pharma IncSeagen Inc.CompletedUrologic Neoplasms | Urinary Bladder Neoplasms | Carcinoma, Transitional Cell | Ureteral Neoplasms | Urothelial Cancer | Urethral Neoplasms | Renal Pelvis NeoplasmsUnited States, Korea, Republic of, Spain, France, Germany, Italy, Japan, Netherlands
-
Novartis PharmaceuticalsActive, not recruitingALK-positive NSCLCBelgium, Spain, Italy, Australia, United States, Hong Kong, Canada, Singapore
-
Hoffmann-La RocheActive, not recruitingNeoplasms | Neoplasms by Histologic Type | Lung Diseases | Neoplasms by Site | Adenocarcinoma | Carcinoma | Neoplasms, Germ Cell and Embryonal | Head and Neck Neoplasms | Carcinoma, Non-Small-Cell Lung | Bronchial Diseases | Respiratory Tract Neoplasms | Thoracic Neoplasms | Carcinoma, Bronchogenic | Neoplasms, Nerve... and other conditionsItaly, Korea, Republic of, Australia, Spain, Argentina, Belgium, Brazil, France, Portugal, United Kingdom, United States, Japan, Mexico, Poland, Norway, Costa Rica, Switzerland, Netherlands, Germany, Sweden, Turkey, Ireland, Panama
-
Maia BiotechnologyRecruitingCarcinoma, Non-Small-Cell LungPoland, Australia, Bulgaria, Hungary
-
Hoffmann-La RocheRecruitingNon-small Cell Lung Cancer (NSCLC)Korea, Republic of, United States, China, Japan, Australia, Thailand, Slovakia, Argentina, Taiwan, Brazil, Hong Kong
-
AstraZenecaCompletedAdvanced Non Small Cell Lung Cancer | Advanced (Inoperable) Non Small Cell Lung CancerUnited States, France, Germany, Korea, Republic of, Taiwan, United Kingdom, Spain, Italy, Japan, Australia
-
Hoffmann-La RocheCompletedSquamous Non-Small Cell Lung CancerUnited States, Spain, France, Australia, Germany, Taiwan, Canada, Argentina, Belgium, Singapore, Brazil, Netherlands, Israel, Portugal, Russian Federation, Japan, Italy, Chile, Latvia, Peru, Ukraine, Lithuania, Slovakia, Bulgaria, Mexico, Austri...
-
Electra Therapeutics Inc.RecruitingSecondary Hemophagocytic Lymphohistiocytosis (sHLH)Netherlands, United States, Spain, Austria, United Kingdom, Italy
-
University of Texas Southwestern Medical CenterRecruitingNon-Small Cell Lung CancerUnited States, Australia, Canada, United Kingdom
-
AbbVieActive, not recruitingNon Small Cell Lung CancerUnited States, Australia, France, Germany, Israel, Italy, Japan, Korea, Republic of, Taiwan
-
IGM Biosciences, Inc.ADC Therapeutics S.A.Active, not recruitingFollicular Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Non-Hodgkin Lymphoma | DLBCLUnited States, Korea, Republic of, Spain, France, Australia, Czechia, Italy
-
Verastem, Inc.AmgenRecruitingNon Small Cell Lung Cancer | KRAS Activating MutationUnited States, Spain, France, United Kingdom, Netherlands, Belgium
-
European Organisation for Research and Treatment...Canadian Cancer Trials Group; ECOG-ACRIN Cancer Research Group; Japan Clinical... and other collaboratorsRecruitingLeiomyosarcoma | Liposarcoma | Retroperitoneal SarcomaUnited States, Japan, France, Spain, Canada, Italy, United Kingdom, Germany, Czechia, Cyprus, Netherlands, Australia, Poland, Slovakia, Denmark
-
Eli Lilly and CompanyUniversity of Colorado, Denver; PPD; Parexel; ICON Clinical Research; Laboratory... and other collaboratorsActive, not recruitingNon Small Cell Lung CancerUnited States, Belgium, Brazil, Russian Federation, Serbia, Spain, United Kingdom, Germany, Australia, Hungary, Italy, Romania, Austria, Croatia, France, Greece, Poland, Portugal, Slovakia, South Africa, Philippines, Canada, Korea,... and more
-
EMD SeronoCompletedLung Cancer | Non Small Cell Lung CarcinomaUnited States, Germany, Austria
-
PfizerCompletedNon-Hodgkin's LymphomaKorea, Republic of, Australia, Czechia, United States, Romania, Germany, France, Poland, Italy, Russian Federation, Serbia
-
EMD SeronoMerck KGaA, Darmstadt, GermanyCompletedNon-small Cell Lung CancerUnited States, Sweden, Australia, Czech Republic, France, Italy, Korea, Republic of, Russian Federation, Spain, United Kingdom, Germany, China, Poland, Romania, Denmark, Hong Kong, Canada, Austria, Belgium, Hungary, Israel, Nether... and more
-
Boehringer IngelheimCompletedLymphoma, FollicularSpain, Belgium, Czechia, France, Croatia, Germany, Austria, New Zealand, Australia, Greece, Hungary, Poland, Russian Federation
-
Genzyme, a Sanofi CompanyCompletedNon-Small-Cell Lung CarcinomaUnited States, France, Italy, Korea, Republic of, Peru, Spain, United Kingdom, Philippines, China, Germany, Hong Kong, Argentina, Austria, Canada, Israel, Taiwan, Mexico, Thailand, Belgium, Australia, Singapore, Netherlands
-
Novartis PharmaceuticalsRecruitingMelanoma | Solid Tumor | High Grade Glioma | Non Small Cell Lung Cancer | Rare CancersSpain, Germany, United States, Argentina, Austria, Denmark, France, Hungary, Netherlands, China, Japan, Thailand
-
Bristol-Myers SquibbCompletedMelanoma | Non-Small Cell Lung Cancer | Advanced CancerCanada, United States, Australia, France, Italy, Spain, Finland, Germany, Norway, Poland, Sweden
-
Peregrine PharmaceuticalsCompletedCarcinoma, Non-Small-Cell Lung | Non-Small Cell Lung Cancer | Nonsmall Cell Lung Cancer | Non-Small-Cell Lung Carcinoma | Non-Small-Cell Lung Cancer Stage IIIB | Non-Small-Cell Lung Cancer Stage IV | Non-Small-Cell Lung Cancer MetastaticUnited States, Australia, Belgium, France, Germany, Greece, Hungary, Italy, Korea, Republic of, Romania, Russian Federation, Spain, Taiwan, Ukraine
-
SecuraBioTerminatedFollicular LymphomaFrance, Italy, Australia, Poland
-
AbbVieCompletedSquamous Non-Small Cell Lung CancerUnited States, Australia, Austria, Belarus, Brazil, Canada, Croatia, Czechia, Denmark, Egypt, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Israel, Italy, Latvia, Lithuania, Mexico, Netherlands, New Zealand, Norway, Poland, P... and more
-
BeiGeneActive, not recruitingRelapsed/Refractory Follicular Non-Hodgkin LymphomaKorea, Republic of, New Zealand, United States, China, Taiwan, Spain, Italy, Australia, Canada, United Kingdom, Belarus, Bulgaria, Czechia, France, Germany, Poland, Russian Federation
-
Medical University of GrazCompletedPatch/Plaque Stage Mycosis FungoidesAustria
-
Hanmi Pharmaceutical Company LimitedTerminatedNon Small Cell Lung CancerUnited States, Australia, Italy, Korea, Republic of, Spain, Germany, Malaysia, Taiwan, Canada, Philippines
-
Eli Lilly and CompanyCompletedA Study of Abemaciclib (LY2835219) in Participants With Stage IV Squamous Non-small Cell Lung CancerNon-Small Cell Lung Cancer Stage IVUnited States, Italy, Spain, Australia, France, Germany, Hungary, Korea, Republic of, Poland, Romania, Russian Federation, Taiwan, Ukraine
-
OncoC4, Inc.BioNTech SERecruitingONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors (PRESERVE-003)Non Small Cell Lung CancerUnited States, Belgium, Canada, France, Germany, Italy, Spain, China, Korea, Republic of, Netherlands, Turkey, United Kingdom, Australia
-
Eisai Inc.CompletedNon-small Cell Lung CancerSpain, United States, Canada, Austria, France, Germany
-
CephalonCompletedNon-Hodgkin's LymphomaUnited States, Canada
-
Klus Pharma Inc.Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.RecruitingNon-small Cell Lung CancerChina, Spain, Turkey, Georgia, Korea, Republic of, Australia, Romania
-
NCIC Clinical Trials GroupCompletedLymphomaUnited States, Canada, Australia
-
Royal Marsden NHS Foundation TrustInstitute of Cancer Research, United Kingdom; National Health Service, United...Active, not recruitingBreast Cancer | Carcinoma, Non-Small-Cell Lung | Prostate CancerUnited Kingdom, Australia
-
Bristol-Myers SquibbWithdrawnNon-Small Cell Lung Cancer | Lung CancerItaly, Korea, Republic of, Turkey, Canada, Spain, Australia, Mexico, Taiwan, France, Germany, Switzerland, Greece, Japan, Austria, United States, Brazil, Czechia
-
Hoffmann-La RocheCompletedNon-Small Cell Lung CancerAustralia, China, Korea, Republic of, Denmark, Germany, Greece, Russian Federation, Hungary, France, Netherlands, New Zealand, Spain, Austria, Slovakia, United Kingdom, Malaysia, Belgium, Lithuania, South Africa, Slovenia, Italy, ... and more